FDA Issues Revised Draft Guidance for Drug Development in Early Alzheimer Disease
Neurology Live,
The FDA recently issued revised draft guidance to assist drug companies in developing treatments for early Alzheimer disease…
The FDA recently issued revised draft guidance to assist drug companies in developing treatments for early Alzheimer disease…
. The 2018 Revised FDA Guidance for Early Alzheimer's Disease: Establishing the Meaningfulness of Treatment Effects.